Location History:
- Shenzhen, CN (2018)
- Guangdong, CN (2020 - 2021)
Company Filing History:
3 out of 49 
2 out of 14 Years Active: 2018-2021
Title: Discovering Innovations by Dongya Zhang in Biomarker Research
Introduction
Dongya Zhang, a prominent inventor based in Guangdong, China, has made significant contributions to the field of biomarker research. With a total of three patents to his name, his work focuses primarily on the development of biomarkers for diseases such as rheumatoid arthritis and colorectal cancer. His innovative solutions not only advance medical research but also hold the potential to transform clinical practices.
Latest Patents
Dongya Zhang's latest patents highlight his expertise in utilizing DNA sequences to predict disease risks. One of his significant contributions is the patent titled "Biomarkers for rheumatoid arthritis and usage thereof," which provides biomarkers and methods for predicting the risk of rheumatoid arthritis (RA). This patent details a process where DNA is extracted from a subject's sample, and the relative abundance of specific biomarkers is calculated to determine the probability of disease presence.
In another groundbreaking patent, "Biomarkers for colorectal cancer," Zhang describes biomarkers and methods associated with microbiota to assess the risk of colorectal cancer (CRC). These innovations underscore the importance of identifying indicators related to microbial health in predicting disease outcomes, demonstrating Zhang's commitment to enhancing disease prediction methodologies.
Career Highlights
Dongya Zhang has worked with well-regarded companies such as BGI Shenzhen and BGI-Shenzhen Co., Limited. His tenure at these organizations has further equipped him with the skills and knowledge necessary to innovate in the biotechnological landscape. The experience gained from these roles has enabled him to focus on complex research topics and contribute significantly to advancements in the field.
Collaborations
Throughout his professional journey, Zhang has collaborated with notable coworkers such as Qiang Feng and Jun Wang. These partnerships have fostered a collaborative environment that enhances the research and innovation process, resulting in the development of impactful solutions that push the boundaries of biomedical science.
Conclusion
Dongya Zhang's work exemplifies the intersection of technology and healthcare, showcasing how innovative research can lead to significant improvements in disease prediction and management. As an inventor, his contributions continue to resonate within the scientific community, paving the way for future advancements in biomarker development and its implications for healthcare.